{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:13:10Z","timestamp":1783437190028,"version":"3.54.6"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1038\/s41401-024-01350-4","type":"journal-article","created":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T10:03:04Z","timestamp":1721901784000},"page":"2611-2624","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["G protein-coupled receptor kinase 2 as a novel therapeutic target for gland fibrosis of Sj\u00f6gren\u2019s syndrome"],"prefix":"10.1038","volume":"45","author":[{"given":"Ru-hong","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu-yun","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-li","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pai-pai","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-xun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-li","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-tong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,25]]},"reference":[{"key":"1350_CR1","first-page":"354","volume":"114","author":"AL Stefanski","year":"2017","unstructured":"Stefanski AL, Tomiak C, Pleyer U, Dietrich T, Burmester GR, D\u00f6rner T. The diagnosis and treatment of Sj\u00f6gren\u2019s syndrome. Dtsch Arztebl Int. 2017;114:354\u201361.","journal-title":"Dtsch Arztebl Int"},{"key":"1350_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.47","volume":"2","author":"P Brito-Zer\u00f3n","year":"2016","unstructured":"Brito-Zer\u00f3n P, Baldini C, Bootsma H, Bowman SJ, Jonsson R, Mariette X, et al. Sj\u00f6gren syndrome. Nat Rev Dis Prim. 2016;2:16047.","journal-title":"Nat Rev Dis Prim"},{"key":"1350_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10238-021-00728-6","volume":"22","author":"S Negrini","year":"2022","unstructured":"Negrini S, Emmi G, Greco M, Borro M, Sardanelli F, Murdaca G, et al. Sj\u00f6gren\u2019s syndrome: a systemic autoimmune disease. Clin Exp Med. 2022;22:9\u201325.","journal-title":"Clin Exp Med"},{"key":"1350_CR4","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/243723","volume":"2015","author":"A Alunno","year":"2015","unstructured":"Alunno A, Carubbi F, Bistoni O, Caterbi S, Bartoloni E, Mirabelli G, et al. T regulatory and T helper 17 cells in primary Sj\u00f6gren\u2019s syndrome: facts and perspectives. Mediators Inflamm. 2015;2015:243723.","journal-title":"Mediators Inflamm"},{"key":"1350_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106199","volume":"80","author":"X Chen","year":"2020","unstructured":"Chen X, Zhang P, Liu Q, Zhang Q, Gu F, Xu S, et al. Alleviating effect of paeoniflorin-6\u2019-O-benzene sulfonate in antigen-induced experimental Sj\u00f6gren\u2019s syndrome by modulating B lymphocyte migration via CXCR5-GRK2-ERK\/p38 signaling pathway. Int Immunopharmacol. 2020;80:106199.","journal-title":"Int Immunopharmacol"},{"key":"1350_CR6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.clim.2017.04.003","volume":"182","author":"J Kiripolsky","year":"2017","unstructured":"Kiripolsky J, McCabe LG, Kramer JM. Innate immunity in Sj\u00f6gren\u2019s syndrome. Clin Immunol. 2017;182:4\u201313.","journal-title":"Clin Immunol"},{"key":"1350_CR7","doi-asserted-by":"publisher","first-page":"14481","DOI":"10.3390\/ijms241914481","volume":"24","author":"J Sarrand","year":"2023","unstructured":"Sarrand J, Soyfoo MS. Involvement of epithelial-mesenchymal transition (EMT) in autoimmune diseases. Int J Mol Sci. 2023;24:14481.","journal-title":"Int J Mol Sci"},{"key":"1350_CR8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00005-020-00591-5","volume":"68","author":"M Sisto","year":"2020","unstructured":"Sisto M, Tamma R, Ribatti D, Lisi S. IL-6 Contributes to the TGF-\u03b21-mediated epithelial to mesenchymal transition in human salivary gland epithelial cells. Arch Immunol Ther Exp (Warsz). 2020;68:27.","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"1350_CR9","doi-asserted-by":"publisher","first-page":"5764","DOI":"10.1038\/sj.onc.1208927","volume":"24","author":"J Zavadil","year":"2005","unstructured":"Zavadil J, B\u00f6ttinger EP. TGF-beta and epithelial-to-mesenchymal transitions. Oncogene. 2005;24:5764\u201374.","journal-title":"Oncogene"},{"key":"1350_CR10","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/cei.13337","volume":"198","author":"M Sisto","year":"2019","unstructured":"Sisto M, Lorusso L, Tamma R, Ingravallo G, Ribatti D, Lisi S. Interleukin-17 and -22 synergy linking inflammation and EMT-dependent fibrosis in Sj\u00f6gren\u2019s syndrome. Clin Exp Immunol. 2019;198:261\u201372.","journal-title":"Clin Exp Immunol"},{"key":"1350_CR11","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.3390\/jcm11123551","volume":"11","author":"M Sisto","year":"2022","unstructured":"Sisto M, Ribatti D, Lisi S. Sj\u00f6gren\u2019s syndrome-related Organs fibrosis: hypotheses and realities. J Clin Med. 2022;11:3551.","journal-title":"J Clin Med"},{"key":"1350_CR12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.clim.2019.04.009","volume":"203","author":"FB Vivino","year":"2019","unstructured":"Vivino FB, Bunya VY, Massaro-Giordano G, Johr CR, Giattino SL, Schorpion A, et al. Sjogren\u2019s syndrome: An update on disease pathogenesis, clinical manifestations and treatment. Clin Immunol. 2019;203:81\u2013121.","journal-title":"Clin Immunol"},{"key":"1350_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.699722","volume":"12","author":"H Yin","year":"2021","unstructured":"Yin H, Pranzatelli TJF, French BN, Zhang N, Warner BM, Chiorini JA, NIDCD\/NIDCR Genomics and Computational Biology Core. Sclerosing sialadenitis is associated with salivary gland hypofunction and a unique gene expression profile in Sj\u00f6gren\u2019s syndrome. Front Immunol. 2021;12:699722.","journal-title":"Front Immunol"},{"key":"1350_CR14","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1007\/s10067-018-4153-8","volume":"37","author":"X Chen","year":"2018","unstructured":"Chen X, Wu H, Wei W. Advances in the diagnosis and treatment of Sjogren\u2019s syndrome. Clin Rheumatol. 2018;37:1743\u20139.","journal-title":"Clin Rheumatol"},{"key":"1350_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.693796","volume":"12","author":"X Wang","year":"2021","unstructured":"Wang X, Zhang TYZ, Guo ZZ, Pu JC, Riaz F, Feng R, et al. The efficiency of hydroxychloroquine for the treatment of primary Sj\u00f6gren\u2019s Syndrome: a systematic review and meta-analysis. Front Pharmacol. 2021;12:693796.","journal-title":"Front Pharmacol"},{"key":"1350_CR16","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.rdc.2016.03.010","volume":"42","author":"FB Vivino","year":"2016","unstructured":"Vivino FB, Carsons SE, Foulks G, Daniels TE, Parke A, Brennan MT, et al. New treatment guidelines for Sj\u00f6gren\u2019s disease. Rheum Dis Clin North Am. 2016;42:531\u201351.","journal-title":"Rheum Dis Clin North Am"},{"key":"1350_CR17","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1001\/jama.2014.7682","volume":"312","author":"JE Gottenberg","year":"2014","unstructured":"Gottenberg JE, Ravaud P, Pu\u00e9chal X, Le Guern V, Sibilia J, Goeb V, et al. Effects of hydroxychloroquine on symptomatic improvement in primary Sj\u00f6gren syndrome: the JOQUER randomized clinical trial. JAMA. 2014;312:249\u201358.","journal-title":"JAMA"},{"key":"1350_CR18","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/j.apsb.2021.01.015","volume":"11","author":"CC Han","year":"2021","unstructured":"Han CC, Li YF, Zhang YW, Wang Y, Cui DQ, Luo TT, et al. Targeted inhibition of GRK2 kinase domain by CP-25 to reverse fibroblast-like synoviocytes dysfunction and improve collagen-induced arthritis in rats. Acta Pharm Sin B. 2021;11:1835\u201352.","journal-title":"Acta Pharm Sin B"},{"key":"1350_CR19","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1042\/CS20191032","volume":"134","author":"CC Han","year":"2020","unstructured":"Han CC, Liu Q, Zhang Y, Li YF, Cui DQ, Luo TT, et al. CP-25 inhibits PGE2-induced angiogenesis by down-regulating EP4\/AC\/cAMP\/PKA-mediated GRK2 translocation. Clin Sci (Lond). 2020;134:331\u201347.","journal-title":"Clin Sci (Lond)"},{"key":"1350_CR20","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.biopha.2018.12.040","volume":"110","author":"XZ Yang","year":"2019","unstructured":"Yang XZ, Zhao YJ, Jia XY, Wang C, Wu YJ, Zhang LL, et al. CP-25 combined with MTX\/ LEF ameliorates the progression of adjuvant-induced arthritis by the inhibition on GRK2 translocation. Biomed Pharmacother. 2019;110:834\u201343.","journal-title":"Biomed Pharmacother"},{"key":"1350_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.822345","volume":"12","author":"N Li","year":"2022","unstructured":"Li N, Shan S, Li XQ, Chen TT, Qi M, Zhang SN, et al. G Protein-coupled receptor kinase 2 as novel therapeutic target in fibrotic diseases. Front Immunol. 2022;12:822345.","journal-title":"Front Immunol"},{"key":"1350_CR22","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.yjmcc.2022.07.012","volume":"172","author":"J Fu","year":"2022","unstructured":"Fu J, Li L, Chen L, Su CP, Feng XL, Huang K, et al. PGE2 protects against heart failure through inhibiting TGF-\u03b21 synthesis in cardiomyocytes and crosstalk between TGF-\u03b21 and GRK2. J Mol Cell Cardiol. 2022;172:63\u201377.","journal-title":"J Mol Cell Cardiol"},{"key":"1350_CR23","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.3390\/ijms22063203","volume":"22","author":"M Sisto","year":"2021","unstructured":"Sisto M, Ribatti D, Lisi S. SMADS-mediate molecular mechanisms in Sj\u00f6gren\u2019s syndrome. Int J Mol Sci. 2021;22:3202.","journal-title":"Int J Mol Sci"},{"key":"1350_CR24","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1038\/s41401-023-01099-2","volume":"44","author":"ZD Zhu","year":"2023","unstructured":"Zhu ZD, Zhang M, Wang Z, Jiang CR, Huang CJ, Cheng HJ, et al. Chronic \u03b2-adrenergic stress contributes to cardiomyopathy in rodents with collagen-induced arthritis. Acta Pharmacol Sin. 2023;44:1989\u20132003.","journal-title":"Acta Pharmacol Sin"},{"key":"1350_CR25","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1136\/jcp.23.8.690","volume":"23","author":"DM Chisholm","year":"1970","unstructured":"Chisholm DM, Waterhouse JP, Mason DK. Lymphocytic sialadenitis in the major and minor glands: a correlation in postmortem subjects. J Clin Pathol. 1970;23:690\u20134.","journal-title":"J Clin Pathol"},{"key":"1350_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1127417","volume":"14","author":"Q Zhan","year":"2023","unstructured":"Zhan Q, Zhang J, Lin Y, Chen W, Fan X, Zhang D. Pathogenesis and treatment of Sjogren\u2019s syndrome: Review and update. Front Immunol. 2023;14:1127417.","journal-title":"Front Immunol"},{"key":"1350_CR27","doi-asserted-by":"publisher","first-page":"9138","DOI":"10.3390\/ijms21239138","volume":"21","author":"X Zhang","year":"2020","unstructured":"Zhang X, Yun JS, Han D, Yook JI, Kim HS, Cho ES. TGF-\u03b2 pathway in salivary gland fibrosis. Int J Mol Sci. 2020;21:9138.","journal-title":"Int J Mol Sci"},{"key":"1350_CR28","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.medcli.2021.06.016","volume":"158","author":"J Mestre-Torres","year":"2022","unstructured":"Mestre-Torres J, Solans-Laque R. Pulmonary involvement in Sj\u00f6gren\u2019s syndrome. Med Clin (Barc). 2022;158:181\u20135.","journal-title":"Med Clin (Barc)"},{"key":"1350_CR29","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1681\/ASN.2015111230","volume":"28","author":"J Voelker","year":"2017","unstructured":"Voelker J, Berg PH, Sheetz M, Duffin K, Shen T, Moser B, et al. Anti-TGF-\u03b21 antibody therapy in patients with diabetic nephropathy. J Am Soc Nephrol. 2017;28:953\u201362.","journal-title":"J Am Soc Nephrol"},{"key":"1350_CR30","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/j.cellsig.2007.02.001","volume":"19","author":"J Ho","year":"2007","unstructured":"Ho J, Chen H, Lebrun JJ. Novel dominant negative Smad antagonists to TGFbeta signaling. Cell Signal. 2007;19:1565\u201374.","journal-title":"Cell Signal"},{"key":"1350_CR31","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1007\/s10753-023-01791-9","volume":"46","author":"J Zhang","year":"2023","unstructured":"Zhang J, Zhang X, Shi X, Liu Y, Cheng D, Tian Q, et al. CXCL9, 10, 11\/CXCR3 axis contributes to the progress of primary Sjogren\u2019s syndrome by activating GRK2 to promote T lymphocyte migration. Inflammation. 2023;46:1047\u201360.","journal-title":"Inflammation"},{"key":"1350_CR32","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1136\/annrheumdis-2015-207751","volume":"75","author":"B Bergum","year":"2016","unstructured":"Bergum B, Koro C, Delaleu N, Solheim M, Hellvard A, Binder V, et al. Antibodies against carbamylated proteins are present in primary Sj\u00f6gren\u2019s syndrome and are associated with disease severity. Ann Rheum Dis. 2016;75:1494\u2013500.","journal-title":"Ann Rheum Dis"},{"key":"1350_CR33","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1136\/ard.2011.153098","volume":"70","author":"M Pertovaara","year":"2011","unstructured":"Pertovaara M, Korpela M. Serum \u03b22 microglobulin correlates with the new ESSDAI in patients with Sj\u00f6gren\u2019s syndrome. Ann Rheum Dis. 2011;70:2236\u20137.","journal-title":"Ann Rheum Dis"},{"key":"1350_CR34","first-page":"1991","volume":"13","author":"HY Ture","year":"2023","unstructured":"Ture HY, Kim NR, Nam EJ. EULAR Sjogren\u2019s syndrome patient reported index (ESSPRI) and other patient-reported outcomes in the assessment of glandular dysfunction in primary Sj\u00f6gren\u2019s syndrome. Life (Basel). 2023;13:1991.","journal-title":"Life (Basel)"},{"issue":"Nov-Dec","key":"1350_CR35","doi-asserted-by":"publisher","first-page":"100","DOI":"10.55563\/clinexprheumatol\/i8g5nd","volume":"133","author":"L de Wolff","year":"2021","unstructured":"de Wolff L, Arends S, Pontarini E, Bombardieri M, Bowman SJ, Bootsma H. Development and performance of the Clinical Trials ESSDAI (ClinTrialsESSDAI), consisting of frequently active clinical domains, in two randomised controlled trials in primary Sj\u00f6gren\u2019s syndrome. Clin Exp Rheumatol. 2021;133(Nov-Dec):100\u20136.","journal-title":"Clin Exp Rheumatol"},{"key":"1350_CR36","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.1038\/sj.emboj.7600794","volume":"24","author":"J Ho","year":"2005","unstructured":"Ho J, Cocolakis E, Dumas VM, Posner BI, Laporte SA, Lebrun JJ. The G protein-coupled receptor kinase-2 is a TGFbeta-inducible antagonist of TGFbeta signal transduction. EMBO J. 2005;24:3247\u201358.","journal-title":"EMBO J"},{"key":"1350_CR37","doi-asserted-by":"publisher","first-page":"C63","DOI":"10.1152\/ajpcell.00347.2021","volume":"322","author":"Y Li","year":"2022","unstructured":"Li Y, Sun Y, Wu N, Ma H. GRK2 promotes activation of lung fibroblast cells and contributes to pathogenesis of pulmonary fibrosis through increasing Smad3 expression. Am J Physiol Cell Physiol. 2022;322:C63\u2013C72.","journal-title":"Am J Physiol Cell Physiol"},{"key":"1350_CR38","first-page":"44","volume":"53 Suppl","author":"JP Feighner","year":"1992","unstructured":"Feighner JP, Boyer WF. Paroxetine in the treatment of depression: a comparison with imipramine and placebo. J Clin Psychiatry. 1992;53 Suppl:44\u201347.","journal-title":"J Clin Psychiatry"},{"key":"1350_CR39","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2165\/00003495-199855010-00007","volume":"55","author":"NS Gunasekara","year":"1998","unstructured":"Gunasekara NS, Noble S, Benfield P. Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders. Drugs. 1998;55:85\u2013120.","journal-title":"Drugs"},{"key":"1350_CR40","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.jaad.2023.01.044","volume":"88","author":"B Wang","year":"2023","unstructured":"Wang B, Huang Y, Tang Y, Zhao ZX, Shi W, Jian D, et al. Paroxetine is an effective treatment for refractory erythema of rosacea: primary results from the prospective rosacea refractory erythema randomized clinical trial. J Am Acad Dermatol. 2023;88:1300\u20137.","journal-title":"J Am Acad Dermatol"},{"key":"1350_CR41","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.comppsych.2018.08.013","volume":"87","author":"D Zhao","year":"2018","unstructured":"Zhao D, Wu Z, Zhang H, Mellor D, Ding L, Wu H, et al. Somatic symptoms vary in major depressive disorder in China. Compr Psychiatry. 2018;87:32\u201337.","journal-title":"Compr Psychiatry"},{"key":"1350_CR42","first-page":"3","volume":"53 Suppl","author":"WF Boyer","year":"1992","unstructured":"Boyer WF, Feighner JP. An overview of paroxetine. J Clin Psychiatry. 1992;53 Suppl:3\u20136.","journal-title":"J Clin Psychiatry"},{"key":"1350_CR43","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41380-022-01824-z","volume":"28","author":"T Kishi","year":"2023","unstructured":"Kishi T, Ikuta T, Sakuma K, Okuya M, Hatano M, Matsuda Y, et al. Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis. Mol Psychiatry. 2023;28:402\u20139.","journal-title":"Mol Psychiatry"},{"key":"1350_CR44","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1517\/14740330802423168","volume":"7","author":"DM Marks","year":"2008","unstructured":"Marks DM, Park MH, Ham BJ, Han C, Patkar AA, Masand PS, et al. Paroxetine: safety and tolerability issues. Expert Opin Drug Saf. 2008;7:783\u201394.","journal-title":"Expert Opin Drug Saf"},{"key":"1350_CR45","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1586\/14737175.4.2.191","volume":"4","author":"PN Dannon","year":"2004","unstructured":"Dannon PN, Lowengrub K, Iancu I, Kotler M. Paroxetine in panic disorder: clinical management and long-term follow-up. Expert Rev Neurother. 2004;4:191\u20138.","journal-title":"Expert Rev Neurother"},{"key":"1350_CR46","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/annrheumdis-2019-216114","volume":"79","author":"M Ramos-Casals","year":"2020","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, Bombardieri S, Bootsma H, De Vita S, D\u00f6rner T, et al. EULAR recommendations for the management of Sj\u00f6gren\u2019s syndrome with topical and systemic therapies. Ann Rheum Dis. 2020;79:3\u201318.","journal-title":"Ann Rheum Dis"},{"key":"1350_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-017-1543-z","volume":"18","author":"SQ Wang","year":"2017","unstructured":"Wang SQ, Zhang LW, Wei P, Hua H. Is hydroxychloroquine effective in treating primary Sjogren\u2019s syndrome: a systematic review and meta-analysis. BMC Musculoskelet Disord. 2017;18:186.","journal-title":"BMC Musculoskelet Disord"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-024-01350-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-024-01350-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-024-01350-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T17:03:11Z","timestamp":1732122191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-024-01350-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,25]]},"references-count":47,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1350"],"URL":"https:\/\/doi.org\/10.1038\/s41401-024-01350-4","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,25]]},"assertion":[{"value":"26 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}